Infleunza vaccination

Dr. Yin started his research on infectious disease prevention in the 1980s. In 1985, Dr. Yin sucessfully isolated the hepatitis A virus, after which, in 2002, he developed the first proprietary inactivated hepatitis A vaccine in China and soon launched it into the China market. Led by Dr. Yin, Sinovac successfully developed the vaccine prducts against SARS, H5N1, H1N1, hepatitis A and B and infleunza. Currently, Sinovac is working on the R&D of EV71 vaccine against hand, foot and mouth disease, and pneumococcal conjugate vaccine...

No abstract text is available yet for this article.

Acute pneumococcal otitis media was produced experimentally in 100% of chinchillas whose middle ear cavities were inoculated with Streptococcus pneumoniae. Although intranasal inoculation with S. pneumoniae led to otitis media in 21% of animals, 66% of the colonized chinchillas that had negative pressure in the middle ear developed otitis media. Intranasal inoculation with S. pneumoniae followed by intranasal inoculation with influenza A virus led to otitis media in 73% of chinchillas, while inoculation with infleunza A virus alone produced otitis media in 4% of animals...

In the spring of 1975 an outbreak of influenza associated with influenza virus A/Scotland/840/74 virus occurred in a residential college where the previous autumn some students had been immunised with a single intranasal dose of Recombinant WRL 105 (H3N2) (A/Okuda/57xA/Finland/4/74) strain live attenuated infleunza virus vaccine. During the outbreak none of seven students who had been vaccinated suffered from influenza but an influenzal illness did occur in four of eleven who had received placebo nose drops only...